|
FY2025
12 months to Jan 3, 2026
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Research and development | |||||
| Restructuring costs | |||||
| Total operating expenses | |||||
| Operating (loss) income | |||||
| Interest expense, net | |||||
| Loss before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Basic and diluted net loss per share: | |||||
| Net loss per share – basic (in dollars per share) | |||||
| Net loss per share – diluted (in dollars per share) | |||||
| Weighted-average shares - basic (in shares) | |||||
| Weighted-average shares (in shares) |
Loading...
